Tackling the challenges of “forever chemicals” in the diagnostics industry.
The FDA recently confirmed that a new rule requiring healthcare providers to notify patients of their breast density status will be released in late 2022 or early 2023.
Newly proposed legislation would establish a risk-based regulatory system for LDT regulation, though not everyone is happy with it.
Senators recently introduced a bill that would require coverage for individuals with a family history of hereditary cancer.
Department of Labor enters final stage of update to ‘regular rate’ rule under FLSA. As we have discussed previously in these updates, the Department of Labor has been working to update the definition
From - Diagnostic Testing & Emerging Technologies
PAMA implementation is so sweeping that it requires a shift in not just payment paradigm but also CPT codes. This has served as the impetus for…
From - G2 Blog
It is a recurrent challenge for human resource professionals: Determining whether an employee is exempt from the overtime requirements of the…